Current Practice of Hepatocellular Carcinoma Surveillance

Acta Medica Indonesiana

Lianda Siregar¹  Imelda Maria Loho¹  Agus Sudiro Waspodo¹  Irsan Hasan² 

[1] Gastroenterology and Hepatology Department, Dharmais National Cancer Center Hospital,Jakarta, Indonesia;Hepatobiliary Divison, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.;

关键词: hepatocellular carcinoma;    surveillance;    ultrasound;    tumor markers;    early detection;   

DOI  :  

来源: DOAJ

【 摘 要 】

Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death worldwide. This is due to the heterogeneity of the tumor biology and lack of curative treatment options. The most significant prognostic factor is detection at early stage and thus, surveillance strategies are of high importance. High-risk patients should undergo ultrasound and tumor marker tests at six-month interval in order to detect HCC at the earlier stage. However, in real-life practice, ultrasound has several limitations and the adherence to HCC surveillance is suboptimal due to various provider, patient, and health-care system factors. In this paper, we will address current methods of HCC surveillance and obstacles found in real-life practice.

【 授权许可】

Unknown